SHOCK: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches seeks to foster multidisciplinary studies that examine shock-related conditions.
NEUTROPHIL PERCENTAGE-TO-ALBUMIN RATIO IS ASSOCIATED WITH 30-DAY ALL-CAUSE MORTALITY IN SEPTIC CHOLANGITIS PATIENTS: A COHORT STUDY https://t.co/R0PnZJ7wBB
THE EFFICACY OF COAGULATION FACTOR CONCENTRATES IN THE MANAGEMENT OF PATIENTS WITH TRAUMA-INDUCED COAGULOPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS https://t.co/O8wmfTZvKU
VASCULAR ENDOTHELIAL DYSFUNCTION IMPROVEMENTS IN PATIENTS WITH UREMIA USING PENTOXIFYLLINE-SUPPRESSING NLRP3 EXPRESSIONS AND HMGB1 RELEASE https://t.co/o35CYVeiiO
MULTIMODAL NUCLEAR FACTOR-ERYTHROID-2โRELATED FACTOR (NRF2) THERAPY IN THE CONTEXT OF MAMMALIAN TARGET OF RAPAMYCIN (MTOR) INHIBITION REPROGRAMS THE ACUTE SYSTEMIC AND PULMONARY IMMUNE RESPONSE AFTER COMBINED BURN AND INHALATION INJURY https://t.co/C9aOH5yq7z
FIBRINOLYTIC DYSFUNCTION AND ENDOTHELIOPATHY AFTER MAJOR THERMAL INJURY: CONSIDERATIONS NEEDED FOR NEW APPROACHES TO BURN SHOCK RESUSCITATION https://t.co/NDRZJ4kqr8
PROTECTION OF MICE AGAINST CECAL LIGATION AND PUNCTURE-INDUCED POLYMICROBIAL SEPSIS BY A FASCIOLA HEPATICA HELMINTH DEFENSE MOLECULE https://t.co/V9T18ESWYv
Vascular endothelial dysfunction improvements in patients with uraemia using pentoxifylline-suppressing NLRP3 expressions and HMGB1 release https://t.co/nBkbkuC8ap
Multimodal Nuclear Factor-Erythroid-2-Related Factor (NRF2) Therapy in the Context of Mammalian Target of Rapamycin (mTOR) Inhibition Reprograms the Acute Systemic and Pulmonary Immune Response after Combined Burn and Inhalation Injury https://t.co/t4ccozUk8G
NETWORK ANALYSIS OF SINGLE-NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH ABERRANT INFLAMMATION IN TRAUMA PATIENTS SUGGESTS A ROLE FOR VESICLE-ASSOCIATED INFLAMMATORY PROGRAMS INVOLVING CD55 https://t.co/MMjrNSD6WI
DETECTION AND QUANTIFICATION OF MICROCIRCULATORY DYSFUNCTION IN SEVERE COVID-19 NOT REQUIRING MECHANICAL VENTILATION: A THREE-ARM COHORT STUDY https://t.co/1TlIodBcq7